pillbase.ru

Glyxambi

Active substance: empagliflozin, linagliptin

empagliflozin, linagliptin

Centralised EU authorisationActive

Marketing holder: Boehringer Ingelheim International GmbH

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Products containing empagliflozin in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
US 25
  • Glyxambi
    TABLET, FILM COATED · EMPAGLIFLOZIN 25 mg/1, LINAGLIPTIN 5 mg/1
    0597-0164
    Boehringer Ingelheim Pharmaceuticals, Inc.
  • Glyxambi
    TABLET, FILM COATED · EMPAGLIFLOZIN 10 mg/1, LINAGLIPTIN 5 mg/1
    0597-0182
    Boehringer Ingelheim Pharmaceuticals, Inc.
  • JARDIANCE
    TABLET, FILM COATED · EMPAGLIFLOZIN 10 mg/1
    50090-4492
    A-S Medication Solutions
  • JARDIANCE
    TABLET, FILM COATED · EMPAGLIFLOZIN 10 mg/1
    50090-6452
    A-S Medication Solutions
  • JARDIANCE
    TABLET, FILM COATED · EMPAGLIFLOZIN 25 mg/1
    50090-6457
    A-S Medication Solutions
All products in this country (25)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-272c-758b-875f-ac5c4b08e323,01a1208d-2aa1-733b-9dfa-5e06933877ab,01a1208d-c645-77f4-8792-c3e899ac7740,01a1208e-7781-7598-b3db-a49916cb774e,01a12090-fcd7-736d-a242-758dc155fa2e;count=11 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/003833
Registration status
Active
ATC code
A10BD19
Sources
  • product · EMA · EMEA/H/C/003833 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/003833 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/003833 · Verified 2026-10-09
  • ingredients.1 · EMA · EMEA/H/C/003833 · Verified 2026-10-09